TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

NCT00023335 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1000

Enrollment

FED

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: Rifapentine
DRUG: Isoniazid

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]